![CEL-SCI Corporation logo](/logos/CVM.webp)
CEL-SCI Corporation
AMEX:CVM
Overview | Financials
Company Name | CEL-SCI Corporation |
Symbol | CVM |
Currency | USD |
Price | 2.18 |
Market Cap | 103,027,018 |
Dividend Yield | 0% |
52-week-range | 1.04 - 3.33 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Geert R. Kersten Esq. |
Website | https://cel-sci.com |
An error occurred while fetching data.
About CEL-SCI Corporation
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD